IPO Date: Dec 1 to Dec 3 2025
Listing Date: Dec 8 2025
1. Marketing and advertisement expenses toward enhancing the awareness and visibility of our brand
2. Setting up a new manufacturing facility at Mauje-Peth in Amravati (“Proposed facility”)
3. General corporate purposes
Off-126, Neo Corporate Plaza Cabin B, Ramchandra Lane Extension Malad (West)
Mumbai
Maharashtra
400064
8433980120
esha@ravelcare.com
www.ravelcare.com
K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Pursuant to Regulation 30 read with Schedule III – Part A of the SEBI Listing Regulations, 2015, Clean Science and Technology has informed the Company has scheduled a conference call for analysts and investors on Saturday, 1st August, 2026 at 4:00 pm (IST) to discuss the unaudited financial results of the Company for the quarter ended 30th June, 2026. The details of the conference call are enclosed. This intimation is also being made available on the Company's website.
The above information is a part of company’s filings submitted to BSE.
Pursuant to regulations 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), 2015 Avenique has informed that it enclosed clipping of Newspaper advertisement published in ‘Active Times’ in English Language and ‘Mumbai Lakshadweep’ in Marathi Language newspaper on 21st July, 2026.
The above information is a part of company’s filings submitted to BSE.
In terms of the requirements of Regulation 34(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Bayer CropScience has submitted the Notice of the 68th AGM of the Company for the Financial Year 2025-26, to be held on Wednesday, August 19, 2026 at 11:30 a.m. IST, through Video Conferencing (‘VC’) / Other Audio-Visual Means (‘OAVM’). The said Notice also forms part of the Annual Report for the Financial Year 2025-26, submitted to the stock exchange vide letter dated July 21, 2026.
The above information is a part of company’s filings submitted to BSE.
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Schedule III thereto, AstraZeneca Pharma India has informed that, Bhavana Agrawal, Executive Director and Chief Financial Officer (‘CFO’) has communicated her resignation from the position of CFO (Key Managerial Personnel) of the Company with effect from the close of business hours on August 31, 2026, pursuant to her appointment to a regional role within the AstraZeneca Group. A copy of the resignation letter is enclosed as Annexure – A. Further, the details as required under the SEBI Master Circular SEBI/HO/49/14/14(7)2025- CFD-POD2/I/3762/2026 dated January 30, 2026 are enclosed as Annexure – B.
The above information is a part of company’s filings submitted to BSE.
No Records Found
The issue size of Ravelcare Ltd. IPO is ₹16.35 - 17.28 crore.
The Ravelcare Ltd. IPO opens for subscription on 2025-12-01 and closes on 2025-12-03.
The price range of Ravelcare Ltd. IPO is ₹123.00 to ₹130.00.
The lot size of Ravelcare Ltd. IPO is 2000 shares.
The registrar of Ravelcare Ltd. IPO is K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.).
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.